AU2009232710A1 - Agent for preventing and/or treating vascular diseases - Google Patents
Agent for preventing and/or treating vascular diseases Download PDFInfo
- Publication number
- AU2009232710A1 AU2009232710A1 AU2009232710A AU2009232710A AU2009232710A1 AU 2009232710 A1 AU2009232710 A1 AU 2009232710A1 AU 2009232710 A AU2009232710 A AU 2009232710A AU 2009232710 A AU2009232710 A AU 2009232710A AU 2009232710 A1 AU2009232710 A1 AU 2009232710A1
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutically acceptable
- clopidogrel
- acceptable salt
- cox
- selective inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008095370 | 2008-04-01 | ||
JP2008-095370 | 2008-04-01 | ||
PCT/JP2009/056708 WO2009123210A1 (fr) | 2008-04-01 | 2009-03-31 | Agent préventif et/ou remède pour maladies vasculaires |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2009232710A1 true AU2009232710A1 (en) | 2009-10-08 |
Family
ID=41135578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2009232710A Abandoned AU2009232710A1 (en) | 2008-04-01 | 2009-03-31 | Agent for preventing and/or treating vascular diseases |
Country Status (13)
Country | Link |
---|---|
US (1) | US20110034504A1 (fr) |
EP (1) | EP2258364A4 (fr) |
JP (1) | JP5589838B2 (fr) |
KR (1) | KR20100137448A (fr) |
CN (1) | CN101983056A (fr) |
AU (1) | AU2009232710A1 (fr) |
BR (1) | BRPI0908584A2 (fr) |
CA (1) | CA2720278A1 (fr) |
IL (1) | IL208231A0 (fr) |
MX (1) | MX2010010869A (fr) |
RU (1) | RU2010144554A (fr) |
WO (1) | WO2009123210A1 (fr) |
ZA (1) | ZA201006660B (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012170839A2 (fr) * | 2011-06-09 | 2012-12-13 | Cardeus Pharmaceuticals, Inc. | Traitement d'une maladie neuro-inflammatoire par des inhibiteurs sélectifs de cox1 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2530247B1 (fr) | 1982-07-13 | 1986-05-16 | Sanofi Sa | Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique |
FR2623810B2 (fr) | 1987-02-17 | 1992-01-24 | Sanofi Sa | Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant |
AUPR878201A0 (en) * | 2001-11-09 | 2001-12-06 | Fujisawa Pharmaceutical Co., Ltd. | New compounds |
CN101237868A (zh) * | 2005-06-13 | 2008-08-06 | 伊兰制药国际有限公司 | 纳米粒氯吡格雷和阿司匹林组合制剂 |
US20080213383A1 (en) * | 2005-09-06 | 2008-09-04 | Astellas Pharma Inc. | Fine particles of poorly water-soluble drug having enteric material adsorbed on particle surface |
WO2007091719A1 (fr) * | 2006-02-07 | 2007-08-16 | Mochida Pharmaceutical Co., Ltd. | Thérapie concomitante par anticorps anti-gpvi et son utilisation médicinale novatrice |
JPWO2008029912A1 (ja) * | 2006-09-07 | 2010-01-21 | 国立大学法人 岡山大学 | シクロオキシゲナーゼ1(cox−1)選択的阻害活性を有するベンズアミドを骨格とする化合物 |
-
2009
- 2009-03-31 US US12/935,472 patent/US20110034504A1/en not_active Abandoned
- 2009-03-31 JP JP2010505948A patent/JP5589838B2/ja not_active Expired - Fee Related
- 2009-03-31 EP EP09728612A patent/EP2258364A4/fr not_active Withdrawn
- 2009-03-31 WO PCT/JP2009/056708 patent/WO2009123210A1/fr active Application Filing
- 2009-03-31 CA CA2720278A patent/CA2720278A1/fr not_active Abandoned
- 2009-03-31 CN CN2009801120173A patent/CN101983056A/zh active Pending
- 2009-03-31 BR BRPI0908584A patent/BRPI0908584A2/pt not_active IP Right Cessation
- 2009-03-31 AU AU2009232710A patent/AU2009232710A1/en not_active Abandoned
- 2009-03-31 MX MX2010010869A patent/MX2010010869A/es not_active Application Discontinuation
- 2009-03-31 KR KR1020107019924A patent/KR20100137448A/ko not_active Application Discontinuation
- 2009-03-31 RU RU2010144554/15A patent/RU2010144554A/ru unknown
-
2010
- 2010-09-16 ZA ZA2010/06660A patent/ZA201006660B/en unknown
- 2010-09-19 IL IL208231A patent/IL208231A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
JPWO2009123210A1 (ja) | 2011-07-28 |
CN101983056A (zh) | 2011-03-02 |
EP2258364A1 (fr) | 2010-12-08 |
IL208231A0 (en) | 2010-12-30 |
BRPI0908584A2 (pt) | 2015-09-15 |
KR20100137448A (ko) | 2010-12-30 |
WO2009123210A1 (fr) | 2009-10-08 |
RU2010144554A (ru) | 2012-05-10 |
CA2720278A1 (fr) | 2009-10-08 |
US20110034504A1 (en) | 2011-02-10 |
EP2258364A4 (fr) | 2012-07-25 |
ZA201006660B (en) | 2011-12-28 |
MX2010010869A (es) | 2010-11-12 |
JP5589838B2 (ja) | 2014-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200817001A (en) | New indications for direct thrombin inhibitors in the cardiovascular field | |
US20230270731A1 (en) | Therapeutic compounds and compositions | |
US20080188497A1 (en) | Dipyridamole, Acetylsalicylic Acid, and Angiotensin II Antagonist Pharmaceutical Compositions | |
SK7502002A3 (en) | Pharmaceutical combinations | |
EA029341B1 (ru) | Способы предоставления антитромбоцитарной терапии | |
TW200817000A (en) | New paediatric indications for direct thrombin inhibitors | |
JP5558348B2 (ja) | シロスタゾールを含むカルボスチリル誘導体の脂肪肝治療剤 | |
KR20100037029A (ko) | 트롬복세인 수용체 길항제를 사용하여 혈전을 치료 및 예방하기 위한 단위 투약 제형 및 방법 | |
US9918964B2 (en) | Reducing platelet activation, aggregation and platelet-stimulated thrombosis or blood coagulation by reducing mitochondrial respiration | |
JP2002255814A (ja) | アスピリンを含有する医薬組成物 | |
EP2258364A1 (fr) | Agent préventif et/ou remède pour maladies vasculaires | |
CN116829168A (zh) | 环孢菌素类似物作为抗血栓形成剂的用途 | |
KR100782246B1 (ko) | 항혈전제와 항혈소판 응집제의 조합체 | |
JPH02157224A (ja) | 1―ジフェニルメチル―4―[(2―(4―メチルフェニル)―5―メチル―1h―イミダゾール―4―イル)メチル]ピペラジン非経口製剤 | |
CN116782911A (zh) | 治疗性化合物、组合物及其使用方法 | |
US20100298205A1 (en) | Methods and compositions for the treatment of conditions related to gastric acid secretion | |
EP4213857A1 (fr) | Composés thérapeutiques, compositions et leurs procédés d'utilisation | |
MX2015002646A (es) | Otamixaban para uso en el tratamiento de sindrome coronario agudo sin elevacion de st en pacientes programados para ser sometidos a injerto de bypass de arteria coronaria. | |
WO2014056418A1 (fr) | Composition pharmaceutique contenant de l'aspirine et du vicagrel | |
US20120277264A1 (en) | Antithrombotic agent | |
TW200403988A (en) | Use of inhibitors of the sodium/hydrogen exchanger for the treatment of thrombotic and inflammatory disorders | |
TW200409638A (en) | Use of MELOXICAM in combination with an antiplatelet agent for treatment of acute coronary syndrome and related conditions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE INVENTION TITLE TO READ AGENT FOR PREVENTING AND/OR TREATING VASCULAR DISEASES |
|
MK1 | Application lapsed section 142(2)(a) - no request for examination in relevant period |